Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age
R Vergara, M Tregnaghi, J Ussher, S Navarro… - European journal of …, 2005 - Springer
High rates of pertussis disease in adolescents suggest that additional boosting against
pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine …
pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine …
Booster vaccination and 1-year follow-up of 4–8-year-old children with a reduced-antigen-content dTpa-IPV vaccine
R Sänger, U Behre, KH Krause, HP Loch… - European journal of …, 2007 - Springer
Reduced-antigen-content pertussis vaccines designed initially for booster vaccination of
adolescents and adults can also be used to vaccinate pre-school age children. Combination …
adolescents and adults can also be used to vaccinate pre-school age children. Combination …
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)
M Knuf, V Vetter, F Celzo, G Ramakrishnan… - Human …, 2010 - Taylor & Francis
Background: The rising incidence of pertussis amongst adults and adolescents in
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …
Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus …
PC Begue, EM Grimprel… - The Pediatric …, 1998 - journals.lww.com
Background. The changing epidemiology of pertussis in France has emphasized the need
for booster vaccinations in adolescents. Although not previously recommended because of …
for booster vaccinations in adolescents. Although not previously recommended because of …
Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine
Pertussis vaccines containing reduced amounts of antigen have been considered primarily
for use in adolescents and adults to date. We evaluated a reduced antigen content …
for use in adolescents and adults to date. We evaluated a reduced antigen content …
Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™ …
F Zhu, S Zhang, Q Hou, Y Zhang, Y Xu, X Ma… - Human …, 2010 - Taylor & Francis
Pertussis continues to circulate in Chinese communities and older children, adolescents and
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …
Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with …
G Ferrera, M Cuccia, G Mereu, G Icardi… - Human vaccines & …, 2012 - Taylor & Francis
Background: Pertussis occurs in older children, adolescents and adults due to waning
immunity after primary vaccination. Booster vaccination for pre-school children has been …
immunity after primary vaccination. Booster vaccination for pre-school children has been …
Combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults
E Grimprel, F Von Sonnenburg, R Sänger, V Abitbol… - Vaccine, 2005 - Elsevier
Many countries recommend diphtheria, tetanus and/or poliomyelitis boosters in adolescents
or adults and the need for pertussis booster vaccination beyond childhood is increasingly …
or adults and the need for pertussis booster vaccination beyond childhood is increasingly …
[HTML][HTML] A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria …
R Marlow, S Kuriyakose, N Mesaros, HH Han… - Vaccine, 2018 - Elsevier
Aim To evaluate the immunogenicity and safety of a reduced antigen diphtheria-tetanus-
acellular pertussis-inactivated poliovirus (dTap-IPV B) vaccine (Boostrix-IPV, GSK) as a pre …
acellular pertussis-inactivated poliovirus (dTap-IPV B) vaccine (Boostrix-IPV, GSK) as a pre …
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …